Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
WRBY
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q3.23
N/A
0.01
vs 0.01
Q4.23
N/A
-0.01
vs -0.17
Q1.24
+33%
0.08
vs 0.06
Q2.24
+50%
0.06
vs 0.04
Q3.24
+400%
0.05
vs 0.01
Q4.24
+200%
0.01
vs -0.01
Q1.25
+50%
0.12
vs 0.08
Q2.25
+33%
0.08
vs 0.06
Q3.25
+74%
0.09
vs 0.05
Q4.25
+464%
0.06
vs 0.01
Sales Growth
YoY
Current
Estimates
Q3.23
+14%
169.8M vs 148.8M
Q4.23
+10%
161.9M vs 146.5M
Q1.24
+16%
200M vs 172M
Q2.24
+13%
188.2M vs 166.1M
Q3.24
+13%
192.4M vs 169.8M
Q4.24
+18%
190.6M vs 161.9M
Q1.25
+12%
223.8M vs 200M
Q2.25
+14%
214.5M vs 188.2M
Q3.25
+17%
224.5M vs 192.4M
Q4.25
+17%
223.7M vs 190.6M
Return on Equity
QoQ
Q1.23
-4%
-0.04
vs -0.07
Q2.23
-5%
-0.05
vs -0.04
Q3.23
-6%
-0.06
vs -0.05
Q4.23
-6%
-0.06
vs -0.06
Q1.24
-1%
-0.01
vs -0.06
Q2.24
-2%
-0.02
vs -0.01
Q3.24
-1%
-0.01
vs -0.02
Q4.24
-2%
-0.02
vs -0.01
Q1.25
+1%
0.01
vs -0.02
Q2.25
0%
-0.00
vs 0.01
Institutionnal Ownership
QoQ
Q4.22
178
178
vs 161
11%
Q1.23
166
166
vs 178
-7%
Q2.23
173
173
vs 166
4%
Q3.23
170
170
vs 173
-2%
Q4.23
187
187
vs 170
10%
Q1.24
181
181
vs 187
-3%
Q2.24
206
206
vs 181
14%
Q3.24
213
213
vs 206
3%
Q4.24
260
260
vs 213
22%
Q1.25
276
276
vs 260
6%
wsj.com
5 hours ago
businesswire.com
6 hours ago
zacks.com
9 hours ago
zacks.com
10 hours ago
zacks.com
11 hours ago
seekingalpha.com
22 hours ago
Quote Panel
Key Metrics
Forecast
2026-Revenue
2026-EPS
2026-EBITDA
Analyst rating
Price Target
26.33(-3.69%)
Number of analyst
3
Last analyst upgrade/downgrade
Citigroup
downgradePrevious: Neutral
2025-07-10
Now: Market Perform
William Blair
upgradePrevious: Not converted
2024-11-07
Now: Outperform
Goldman Sachs
upgradePrevious: Not converted
2024-10-21
Now: Buy
JMP Securities
upgradePrevious: Not converted
2024-08-22
Now: Outperform
Relative Strength
WRBY
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
---|---|---|---|